IBDEI1N5 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29150,1,2,0)
 ;;=2^Asp/Inj Intermediate Jt w/o US
 ;;^UTILITY(U,$J,358.3,29150,1,3,0)
 ;;=3^20605
 ;;^UTILITY(U,$J,358.3,29151,0)
 ;;=20610^^173^1859^4^^^^1
 ;;^UTILITY(U,$J,358.3,29151,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29151,1,2,0)
 ;;=2^Asp/Inj Major Jt w/o US
 ;;^UTILITY(U,$J,358.3,29151,1,3,0)
 ;;=3^20610
 ;;^UTILITY(U,$J,358.3,29152,0)
 ;;=20550^^173^1859^9^^^^1
 ;;^UTILITY(U,$J,358.3,29152,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29152,1,2,0)
 ;;=2^Inject Tendon/Ligament/Cyst 
 ;;^UTILITY(U,$J,358.3,29152,1,3,0)
 ;;=3^20550
 ;;^UTILITY(U,$J,358.3,29153,0)
 ;;=J1100^^173^1859^8^^^^1
 ;;^UTILITY(U,$J,358.3,29153,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29153,1,2,0)
 ;;=2^Dexamethasone Sodium Phos 1 mg
 ;;^UTILITY(U,$J,358.3,29153,1,3,0)
 ;;=3^J1100
 ;;^UTILITY(U,$J,358.3,29154,0)
 ;;=J0800^^173^1859^7^^^^1
 ;;^UTILITY(U,$J,358.3,29154,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29154,1,2,0)
 ;;=2^Corticotropin Inj up to 40 units
 ;;^UTILITY(U,$J,358.3,29154,1,3,0)
 ;;=3^J0800
 ;;^UTILITY(U,$J,358.3,29155,0)
 ;;=J1040^^173^1859^10^^^^1
 ;;^UTILITY(U,$J,358.3,29155,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29155,1,2,0)
 ;;=2^Methylprednisolone 80 Mg Inj
 ;;^UTILITY(U,$J,358.3,29155,1,3,0)
 ;;=3^J1040
 ;;^UTILITY(U,$J,358.3,29156,0)
 ;;=20606^^173^1859^1^^^^1
 ;;^UTILITY(U,$J,358.3,29156,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29156,1,2,0)
 ;;=2^Asp/Inj Intermediate Jt w/ US
 ;;^UTILITY(U,$J,358.3,29156,1,3,0)
 ;;=3^20606
 ;;^UTILITY(U,$J,358.3,29157,0)
 ;;=20611^^173^1859^3^^^^1
 ;;^UTILITY(U,$J,358.3,29157,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29157,1,2,0)
 ;;=2^Asp/Inj Major Jt w/ US
 ;;^UTILITY(U,$J,358.3,29157,1,3,0)
 ;;=3^20611
 ;;^UTILITY(U,$J,358.3,29158,0)
 ;;=20604^^173^1859^5^^^^1
 ;;^UTILITY(U,$J,358.3,29158,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29158,1,2,0)
 ;;=2^Asp/Inj Small Jt w/ US
 ;;^UTILITY(U,$J,358.3,29158,1,3,0)
 ;;=3^20604
 ;;^UTILITY(U,$J,358.3,29159,0)
 ;;=97762^^173^1860^1^^^^1
 ;;^UTILITY(U,$J,358.3,29159,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29159,1,2,0)
 ;;=2^C/O for Orthotic/Prosth Use,Est Pt,ea 15min
 ;;^UTILITY(U,$J,358.3,29159,1,3,0)
 ;;=3^97762
 ;;^UTILITY(U,$J,358.3,29160,0)
 ;;=97760^^173^1860^2^^^^1
 ;;^UTILITY(U,$J,358.3,29160,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29160,1,2,0)
 ;;=2^Orthotic Mgmt and Training,ea 15min
 ;;^UTILITY(U,$J,358.3,29160,1,3,0)
 ;;=3^97760
 ;;^UTILITY(U,$J,358.3,29161,0)
 ;;=97761^^173^1860^3^^^^1
 ;;^UTILITY(U,$J,358.3,29161,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29161,1,2,0)
 ;;=2^Prosthetic Training,ea 15min
 ;;^UTILITY(U,$J,358.3,29161,1,3,0)
 ;;=3^97761
 ;;^UTILITY(U,$J,358.3,29162,0)
 ;;=97110^^173^1861^7^^^^1
 ;;^UTILITY(U,$J,358.3,29162,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29162,1,2,0)
 ;;=2^Therapeutic Exercises, Ea 15 Min
 ;;^UTILITY(U,$J,358.3,29162,1,3,0)
 ;;=3^97110
 ;;^UTILITY(U,$J,358.3,29163,0)
 ;;=97750^^173^1861^5^^^^1
 ;;^UTILITY(U,$J,358.3,29163,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29163,1,2,0)
 ;;=2^Physical Perform Test, Ea 15 Min
 ;;^UTILITY(U,$J,358.3,29163,1,3,0)
 ;;=3^97750
 ;;^UTILITY(U,$J,358.3,29164,0)
 ;;=97112^^173^1861^4^^^^1
 ;;^UTILITY(U,$J,358.3,29164,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29164,1,2,0)
 ;;=2^Neuromuscular Reeduc,  Ea 15 Min
 ;;^UTILITY(U,$J,358.3,29164,1,3,0)
 ;;=3^97112
 ;;^UTILITY(U,$J,358.3,29165,0)
 ;;=97113^^173^1861^1^^^^1
 ;;^UTILITY(U,$J,358.3,29165,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29165,1,2,0)
 ;;=2^Aquatic Exercises,ea 15min
 ;;^UTILITY(U,$J,358.3,29165,1,3,0)
 ;;=3^97113
 ;;
 ;;$END ROU IBDEI1N5
